Animal Models of Alzheimer's Disease: An Understanding of Pathology and Therapeutic Avenues

REFERENCES

• Abrahamson, E. E., Ikonomovic, M. D., Ciallella, J. R., Hope, C. E., Paljug, W. R., Isanski, B. A., (2006). Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: Implications for clinical outcome. Experimental Neurology, 197(2), 437–450.
   PubMed Web of Science ®Google Scholar
• Bai, Q., Garver, J. A., Hukriede, N. A., & Burton, E. A. (2007). Generation of a transgenic zebrafish model of tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Research, 35(19), 6501–6516.
   PubMed Web of Science ®Google Scholar
• Bard, F., Cannon, C., Barbour, R., Burke, R. L., Games, D., Grajeda, H., (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine, 6(8), 916–919.
   PubMed Web of Science ®Google Scholar
• Behl, C. (2000). Apoptosis and Alzheimer's disease. Journal of Neural Transmission, 107(11), 1325–1344.
   PubMed Web of Science ®Google Scholar
• Bennett, S. P., Boyd, T., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., (2009). A novel technique for simultaneous bilateral brain infusions in a mouse model of neurodegenerative disease. Journal of Neuroscience Methods, 184(2), 320– 326.
   PubMed Web of Science ®Google Scholar
• Bharathi, Shama Sundar, N. M., Rao, T. S. S., Ravid, R., & Rao, K. S. J. (2006). A new insight into Al-maltolate treated aged rabbit brain as Alzheimer's animal model. Brain Research Reviews, 52(2), 275–292.
   PubMedGoogle Scholar
• Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005). Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron, 45(5), 675–688.
   PubMed Web of Science ®Google Scholar
• Calissano, P., Matrone, C., & Amadoro, G. (2009). Apoptosis and in vitro Alzheimer disease neuronal models. Communicative and Integrative Biology, 2(2), 163–169.
   PubMedGoogle Scholar
• Capsoni, S., & Cattaneo, A. (2006). On the molecular basis linking nerve growth factor (NGF) to Alzheimer's disease. Cell and Molecular Neurobiology, 26(4–6), 619–633.
   PubMed Web of Science ®Google Scholar
• Citron, M. (2002). Alzheimer's disease: treatments in discovery and development. Nature Neuroscience, 5(Suppl), 1055–1057.
   PubMed Web of Science ®Google Scholar
• DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J. C., Paul, S. M., & Holtzman, D. M. (2001). Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proceedings of National Academy of Sciences USA, 98(15), 8850– 8855.
   PubMed Web of Science ®Google Scholar
• Dhenain, M., El Tannir El Tayara, N., Wu, T. D., Guegan, M., Volk, A., & Quintana, C., (2009). Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiology of Aging, 30(1), 41–53.
   PubMed Web of Science ®Google Scholar
• Dickson, D. W. (2004). Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect? Journal of Clinical Investigation, 114(1), 23–27.
   PubMed Web of Science ®Google Scholar
• Dong, Y., Zhang, G., Zhang, B., Moir, R. D., Xia, W., Marcantonio, E. R., (2009). The common inhalational anesthetic sevoflurane induces apoptosis and increases β-amyloid protein levels. Archives of Neurology, 66(5), 620–631.
   PubMedGoogle Scholar
• Du, J., Sun, B., Chen, K., Zhang, L., Liu, S., Gu, Q., (2009). Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. PLoS ONE, 4(5), e5530.
   Web of Science ®Google Scholar
• Feng, Y., Wang, X. P., Yang, S. G., Wang, Y. J., Zhang, X., Du, X. T., (2009). Resveratrol inh`ibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology, 30(6), 986–995.
   PubMed Web of Science ®Google Scholar
• Garcia-Sierra, F., Mondragon-Rodriguez, S., & Basurto-Islas, G. (2008). Truncation of tau protein and its pathological significance in Alzheimer's disease. Journal of Alzheimers Disease, 14(4), 401–409.
   PubMed Web of Science ®Google Scholar
• Garringer, H. J., Murrell, J., D'Adamio, L., Ghetti, B., & Vidal, R. (in press). Modeling familial British and Danish dementia. Brain Structure and Function.
   Web of Science ®Google Scholar
• Gaspar, R. C., Villarreal, S. A., Bowles, N., Hepler, R. W., Joyce, J. G., & Shughrue, P. J. (in press). Oligomers of beta-amyloid are sequestered into and seed plaques in the brains of an AD mouse model. Experimental Neurology.
   Web of Science ®Google Scholar
• Gerhard, G. S., Kauffman, E. J., Wang, X., Stewart, R., Moore, J. L., Kasales, (2002). Life spans and senescent phenotypes in two strains of Zebrafish (Danio rerio). Experimental Gerontology, 37(8–9), 1055–1068.
   PubMed Web of Science ®Google Scholar
• Ghribi, O., DeWitt, D. A., Forbes, M. S., Arad, A., Herman, M. M., & Savory, J. (2001a). Cyclosporin A inhibits Al-induced cytochrome c release from mitochondria in aged rabbits. Journal of Alzheimers Disease, 3(4), 387–391.
   PubMed Web of Science ®Google Scholar
• Ghribi, O., DeWitt, D. A., Forbes, M. S., Herman, M. M., & Savory, J. (2001). Coinvolvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. Brain Research, 903(1–2), 66–73.
   PubMed Web of Science ®Google Scholar
• Ghribi, O., Herman, M. M., DeWitt, D. A., Forbes, M. S., & Savory, J. (2001). Abeta(1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of GADD 153 and NF-kappaB. Brain Research Molecular Brain Research, 96(1–2), 30–38.
   PubMedGoogle Scholar
• Ghribi, O., Herman, M. M., Forbes, M. S., DeWitt, D. A., & Savory, J. (2001). GDNF protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochondrial Bax translocation. Neurobiology of Disease, 8(5), 764–773.
   PubMed Web of Science ®Google Scholar
• Ghribi, O., Herman, M. M., & Savory, J. (2002). The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus. Neuroscience Letters, 324(3), 217–221.
   PubMed Web of Science ®Google Scholar
• Gotz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D., (in press). Animal models reveal role for tau phosphorylation in human disease. Biochimica Biophysica Acta.
   Web of Science ®Google Scholar
• Hook, V. Y., Kindy, M., & Hook, G. (2008). Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. Journal of Biological Chemistry, 283(12), 7745–7753.
   PubMed Web of Science ®Google Scholar
• Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., (1998). Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393(6686), 702–705.
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Jr., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., (2004). In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magnetic Resonance in Medicine, 52(6), 1263–1271.
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Jr., Marjanska, M., Wengenack, T. M., Reyes, D. A., Curran, G. L., Lin, J., (2007). Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Neuroscientist, 13(1), 38–48.
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Jr., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., (2005). In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. Journal of Neuroscience, 25(43), 10041–10048.
   PubMed Web of Science ®Google Scholar
• Jantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., (2002). Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. Journal of Neuroscience, 22(6), 2246–2254.
   PubMed Web of Science ®Google Scholar
• Jeong, J. Y., Kwon, H. B., Ahn, J. C., Kang, D., Kwon, S. H., Park, J. A., (2008). Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Research Bulletin, 75(5), 619–628.
   PubMed Web of Science ®Google Scholar
• Lim, G. P., Chu, T., Yang, F. S., Beech, W., Frautschy, S. A., & Cole, G. M. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience, 21(21), 8370–8377.
   PubMed Web of Science ®Google Scholar
• Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., (2000). Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. Journal of Neuroscience, 20(15), 5709–5714.
   PubMed Web of Science ®Google Scholar
• Lim, G. P., Yang, F., Chu, T., Gahtan, E., Ubeda, O., Beech, W., (2001). Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiology of Aging, 22(6), 983–991.
   PubMed Web of Science ®Google Scholar
• Price, K. A., Caragounis, A., Paterson, B. M., Filiz, G., Volitakis, I., Masters, C. L., (2009). Sustained Activation of glial cell epidermal growth factor receptor by bis(thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity. Journal of Medicinal Chemistry, 52(21), 6606–6620.
   PubMed Web of Science ®Google Scholar
• Mattson, M. P., & Magnus, T. (2006). Ageing and neuronal vulnerability. Nature Reviews Neuroscience, 7(4), 278–294.
   PubMed Web of Science ®Google Scholar
• Maxwell, M. M. (2009). RNAi applications in therapy development for neurodegenerative disease. Current Pharmaceutical Design, 15(34), 3977–3991.
   PubMed Web of Science ®Google Scholar
• Manzano, S., Gonzalez, J., Marcos, A., Payno, M., Villanueva, C., & Matias-Guiu, J. (2009). Experimental models in Alzheimer's disease. Neurologia, 24(4), 255–262.
   PubMed Web of Science ®Google Scholar
• Meadowcroft, M. D., Connor, J. R., Smith, M. B., & Yang, Q. X. (2009). Magnetic resonance imaging and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. Journal of Magnetic Resonance and Imaging, 29(5), 997–1007.
   PubMed Web of Science ®Google Scholar
• Miltiadous, P., Stamatakis, A., & Stylianopoulou, F. (in press). Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat. Cell and Molecular Neurobiology.
   Web of Science ®Google Scholar
• Movsesyan, N., Ghochikyan, A., Mkrtichyan, M., Petrushina, I., Davtyan, H., Olkhanud, P. B., (2008). Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine—A novel immunotherapeutic strategy. PLoS ONE, 3(5), e2124.
   Web of Science ®Google Scholar
• Murphy, M. P., & Levine, H. (2010). Alzheimer's disease and the amyloid-beta peptide. Journal of Alzheimers Disease, 19(1), 311–323.
   PubMed Web of Science ®Google Scholar
• Obulesu, M., Rao, D. M., & Shama Sundar, N. M. (2009). Studies on genomic DNA stability in aluminium-maltolate treated aged New Zealand rabbit: Relevance to the Alzheimer's animal model. Journal of Clinical Medicine and Research, 1(4), 212– 218.
   PubMedGoogle Scholar
• Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004). Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron, 43(3), 321–332.
   PubMed Web of Science ®Google Scholar
• Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron, 39(3), 409–421.
   PubMed Web of Science ®Google Scholar
• Oddo, S., Vasilevko, V., Caccamo, A., Kitazawa, M., Cribbs, D. H., & LaFerla, F. M. (2006). Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. Journal of Biological Chemistry, 281(51), 39413–39423.
   PubMed Web of Science ®Google Scholar
• Paquet, D., Bhat, R., Sydow, A., Mandelkow, E. M., Berg, S., Hellberg, S., (2009). A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. Journal of Clinical Investigation, 119(5), 1382–1395.
   PubMed Web of Science ®Google Scholar
• Peng, Y., Xing, C., Xu, S., Lemere, C. A., Chen, G., Liu, B., (2009). l-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats. European Journal of Pharmacology, 621(1–3), 38–45.
   PubMed Web of Science ®Google Scholar
• Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., & Davies, P. (2009). Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. Journal of Neuroscience, 29(34), 10741–10749.
   PubMed Web of Science ®Google Scholar
• Ramalho, R. M., Viana, R. J., Castro, R. E., Steer, C. J., Low, W. C., & Rodriguez, C. M. (2008). Apoptosis in transgenic mice expressing the P301L mutated form of human tau. Molecular medicine, 14(5–6), 309–317.
   PubMed Web of Science ®Google Scholar
• Rao, K. S. J., Anitha, S., & Latha, K. S. (2000). Aluminium induced neurodegeneration in hippocampus of aged rabbits mimics AD. Alzheimer's Reports, 3, 83–88.
   Google Scholar
• Rohn, T. T., Vyas, V., Hernandez-estrada, T., Nichol, K. E., Christie, L. A., & Head, E. (2008). Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the antiapoptotic protein bcl-2. Journal of Neuroscience, 28(12), 3051–3059.
   PubMed Web of Science ®Google Scholar
• Roberts, R. C. (1961). The lifetime growth and reproduction of selected strains of mice. Heredity, 16, 369–381.
   Web of Science ®Google Scholar
• Ruberti, F., Capsoni, S., Comparini, A., Di Daniel, E., Franzot, J., Gonfloni, S., (2000). Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy. Journal of Neuroscience, 20(7), 2589–2601.
   PubMed Web of Science ®Google Scholar
• Savory, J., Jagannatha, K. S. Rao., Yue, H., Philip, R., Ledata, (1999). Age-related hippocampal changes in Bcl3-2: Bax Ratio, Oxidative Stress, Redox-Active iron and apoptosis associated with Al induced neurodegeneration: Increased susceptibility with aging. Neurotoxicology, 20(5), 805–818.
   PubMed Web of Science ®Google Scholar
• Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173–177.
   PubMed Web of Science ®Google Scholar
• Shimohama, S. (2000). Apoptosis in Alzheimer's disease—An update. Apoptosis, 5(1), 9–16.
   PubMed Web of Science ®Google Scholar
• Shi, Q., & Gibson, G. E. (2007). Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Disease and Associated Disorders, 21(4), 276–291.
   PubMed Web of Science ®Google Scholar
• Small, G. W., Rabins, P. V., Barry, P. P. Buckholtz, N. S., DeKosky, S. T., Ferris, S. H., (1997). Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. The Journal of the American Medical Association, 278(16), 1363–1371.
   PubMed Web of Science ®Google Scholar
• Squitti, R., & Salustri, C. (2009). Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease. Current Alzheimer's Research, 6(6), 476–487.
   PubMed Web of Science ®Google Scholar
• Sugama, S., Takenouchi, T., Cho, B. P., Joh, T. H., Hashimoto, M., & Kitani, H. (2009). Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflammation and Allergy Drug Targets, 8, 277–284.
   Google Scholar
• Terrence Town. (2009). Alternative Aβimmunotherapy approaches for Alzheimer's disease.CNS and Neurological Desorders Drug Targets, 8(4), 144–127.
   PubMedGoogle Scholar
• Tomasiewicz, H. G., Flaherty, D. B., Soria, J. P., & Wood, J. G. (2002). Transgenic zebrafish model of neurodegeneration. Journal of Neuroscience Research, 70(6), 734–745.
   PubMed Web of Science ®Google Scholar
• Trinchese, F., Fa, M., Liu, S., Zhang, H., Hidalgo, A., Schmidt, S. D., (2008). Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. Journal of Clinical Investigation, 118(8), 2796–2807.
   PubMed Web of Science ®Google Scholar
• Vanhoutte, G., Dewachter, I., Borghgraef, P., Van Leuven, F., & Van Der Linden, A. (2005). Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magnetic Resonance in Medicine, 53(3), 607–613.
   PubMed Web of Science ®Google Scholar
• van Groen, T., Kiliaan, A. J., & Kadish, I. (2006). Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. Neurobiology of Disease, 23(3), 653–662.
   PubMed Web of Science ®Google Scholar
• Velliquette, R. A., O’Connor, T., & Vassar, R. (2005). Energy inhibition elevates betasecretase levels and activity and is potentially amyloidogenic in APP transgenic mice: Possible early events in Alzheimer's disease pathogenesis. Journal of Neuroscience, 25(47), 10874–10883.
   PubMed Web of Science ®Google Scholar
• Wengenack, T. M., Whelan, S., Curran, G. L., Duff, K. E., & Poduslo, J. F. (2000). Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience, 101(4), 939–944.
   PubMed Web of Science ®Google Scholar
• Wright, J. W., & Harding, J. W. (in press). The brain RAS and Alzheimer's disease. Experimental Neurology.
   Web of Science ®Google Scholar
• Zon, L. I., & Peterson, R. T.,(2005). In vivo drug discovery in the zebrafish. Nature Reviews Drug Discovery, 4(1), 35–44.
   PubMed Web of Science ®Google Scholar